Literature DB >> 25480809

Treatment of systemic sclerosis with tocilizumab.

Marisa Fernandes das Neves1, Susana Oliveira2, Marta C Amaral1, José Delgado Alves3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25480809     DOI： 10.1093/rheumatology/keu435

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN： 1462-0324            Impact factor:   7.580


× No keyword cloud information.
  7 in total

Review 1.  Interstitial lung disease in systemic sclerosis: current and future treatment.

Authors:  Roberto Giacomelli; Vasiliki Liakouli; Onorina Berardicurti; Piero Ruscitti; Paola Di Benedetto; Francesco Carubbi; Giuliana Guggino; Salvatore Di Bartolomeo; Francesco Ciccia; Giovanni Triolo; Paola Cipriani
Journal:  Rheumatol Int       Date:  2017-01-06       Impact factor: 2.631

2.  Immunotherapy of systemic sclerosis.

Authors:  Christina G Katsiari; Theodora Simopoulou; Ioannis Alexiou; Lazaros I Sakkas
Journal:  Hum Vaccin Immunother       Date:  2018-07-16       Impact factor: 3.452

3.  Efficacy of subcutaneous tocilizumab in patients with rheumatoid arthritis and systemic sclerosis overlap syndrome: a report of two cases and review of the literature.

Authors:  Hiroki Wakabayashi; Hitoshi Kino; Makoto Kondo; Keiichi Yamanaka; Masahiro Hasegawa; Akihiro Sudo
Journal:  BMC Rheumatol       Date:  2019-04-24

Review 4.  Is biological therapy in systemic sclerosis the answer?

Authors:  Durga Prasanna Misra; Sakir Ahmed; Vikas Agarwal
Journal:  Rheumatol Int       Date:  2020-01-20       Impact factor: 2.631

Review 5.  Recent advances in the treatment of skin involvement in systemic sclerosis.

Authors:  Yoshihide Asano
Journal:  Inflamm Regen       Date:  2017-06-12

Review 6.  Therapeutic Options for Systemic Sclerosis: Current and Future Perspectives in Tackling Immune-Mediated Fibrosis.

Authors:  Theodoros-Ioannis Papadimitriou; Arjan van Caam; Peter M van der Kraan; Rogier M Thurlings
Journal:  Biomedicines       Date:  2022-01-29

Review 7.  Spotlight on tocilizumab and its potential in the treatment of systemic sclerosis.

Authors:  Lazaros I Sakkas
Journal:  Drug Des Devel Ther       Date:  2016-08-29       Impact factor: 4.162
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.